SK bioscience Statistics
Total Valuation
SK bioscience has a market cap or net worth of KRW 3.87 trillion. The enterprise value is 3.41 trillion.
Market Cap | 3.87T |
Enterprise Value | 3.41T |
Important Dates
The last earnings date was Tuesday, August 12, 2025.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SK bioscience has 78.37 million shares outstanding. The number of shares has increased by 1.35% in one year.
Current Share Class | 78.37M |
Shares Outstanding | 78.37M |
Shares Change (YoY) | +1.35% |
Shares Change (QoQ) | +0.25% |
Owned by Insiders (%) | 0.11% |
Owned by Institutions (%) | 2.91% |
Float | 25.88M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 7.23 |
PB Ratio | 1.91 |
P/TBV Ratio | 2.31 |
P/FCF Ratio | n/a |
P/OCF Ratio | 2,209.57 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -64.62 |
EV / Sales | 6.37 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -18.31 |
Financial Position
The company has a current ratio of 4.48, with a Debt / Equity ratio of 0.20.
Current Ratio | 4.48 |
Quick Ratio | 3.83 |
Debt / Equity | 0.20 |
Debt / EBITDA | n/a |
Debt / FCF | -2.16 |
Interest Coverage | -18.14 |
Financial Efficiency
Return on equity (ROE) is -2.44% and return on invested capital (ROIC) is -4.19%.
Return on Equity (ROE) | -2.44% |
Return on Assets (ROA) | -3.71% |
Return on Invested Capital (ROIC) | -4.19% |
Return on Capital Employed (ROCE) | -5.64% |
Revenue Per Employee | 583.33M |
Profits Per Employee | -57.47M |
Employee Count | 917 |
Asset Turnover | 0.22 |
Inventory Turnover | 3.01 |
Taxes
Income Tax | -55.52B |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.25% in the last 52 weeks. The beta is 1.22, so SK bioscience's price volatility has been higher than the market average.
Beta (5Y) | 1.22 |
52-Week Price Change | -4.25% |
50-Day Moving Average | 47,447.00 |
200-Day Moving Average | 46,029.75 |
Relative Strength Index (RSI) | 60.00 |
Average Volume (20 Days) | 143,397 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SK bioscience had revenue of KRW 534.91 billion and -52.70 billion in losses. Loss per share was -676.46.
Revenue | 534.91B |
Gross Profit | 44.58B |
Operating Income | -142.91B |
Pretax Income | -101.37B |
Net Income | -52.70B |
EBITDA | -69.20B |
EBIT | -142.91B |
Loss Per Share | -676.46 |
Balance Sheet
The company has 1.10 trillion in cash and 402.11 billion in debt, giving a net cash position of 694.66 billion or 8,863.96 per share.
Cash & Cash Equivalents | 1.10T |
Total Debt | 402.11B |
Net Cash | 694.66B |
Net Cash Per Share | 8,863.96 |
Equity (Book Value) | 2.02T |
Book Value Per Share | 22,869.85 |
Working Capital | 1.12T |
Cash Flow
In the last 12 months, operating cash flow was 1.75 billion and capital expenditures -187.69 billion, giving a free cash flow of -185.94 billion.
Operating Cash Flow | 1.75B |
Capital Expenditures | -187.69B |
Free Cash Flow | -185.94B |
FCF Per Share | -2,372.56 |
Margins
Gross margin is 8.33%, with operating and profit margins of -26.72% and -9.85%.
Gross Margin | 8.33% |
Operating Margin | -26.72% |
Pretax Margin | -18.95% |
Profit Margin | -9.85% |
EBITDA Margin | -12.94% |
EBIT Margin | -26.72% |
FCF Margin | n/a |
Dividends & Yields
SK bioscience does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.35% |
Shareholder Yield | n/a |
Earnings Yield | -1.36% |
FCF Yield | -4.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SK bioscience has an Altman Z-Score of 3.48 and a Piotroski F-Score of 3.
Altman Z-Score | 3.48 |
Piotroski F-Score | 3 |